Enable Injections Inc (Enable Injections) is a healthcare company that develops and manufactures drug delivery systems. It offers enFuse, a wearable delivery system that consists of the enFuse paired with a transfer system option. It also offers syringe transfer system, vial transfer system and dual vial transfer system. Enable Injections Smart enFuse is in development for compatibility with digital infrastructure, enabling data storage and communication capability. Its partners include Apellis Pharmaceuticals, CSL Behring, Sanofi, Roche and Genentech and Viridian Therapeutics. Enable Injections is headquartered in Cincinnati, Ohio, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Enable Injections Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Enable Injections Inc Company Overview
- Enable Injections Inc Company Snapshot
- Enable Injections Inc Pipeline Products and Ongoing Clinical Trials Overview
- Enable Injections Inc - Pipeline Analysis Overview
- Enable Injections Inc - Key Facts
- Enable Injections Inc - Major Products and Services
- Enable Injections Inc Pipeline Products by Development Stage
- Enable Injections Inc Ongoing Clinical Trials by Trial Status
- Enable Injections Inc Pipeline Products Overview
- Enfuse Differentiated Molecular Drug Delivery System
- Enfuse Differentiated Molecular Drug Delivery System Product Overview
- enFuse Dual Vial Transfer System
- enFuse Dual Vial Transfer System Product Overview
- enFuse On-Body Infusor
- enFuse On-Body Infusor Product Overview
- enFuse Syringe Transfer System
- enFuse Syringe Transfer System Product Overview
- enFuse Vial Transfer System
- enFuse Vial Transfer System Product Overview
- Enfuse with SER-252
- Enfuse with SER-252 Product Overview
- Enfuse with SER-252 Clinical Trial
- Enable Injections Inc - Key Competitors
- Enable Injections Inc - Key Employees
- Enable Injections Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Enable Injections Inc, Recent Developments
- Apr 25, 2025: Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
- Mar 26, 2025: Enable Injections’ syringe transfer system gains CE mark approval
- Jan 09, 2025: New Sarclisa Subcutaneous Formulation Met Co-primary Endpoints in the IRAKLIA Phase 3 Study in Multiple Myeloma
- Sep 12, 2024: Enable Injections Announces Agreement with Sobi to Develop and Distribute Aspaveli in Combination with Enfuse in Sobi Territories
- May 07, 2024: Enable Injections Expands Strategic Partnership with Roche
- Feb 14, 2024: Enable Injections Announces Plans to Expand Manufacturing Facilities and Corporate Headquarters
- Nov 07, 2023: Enable Injections Enhances Board with Addition of Vickie Capps
- Oct 02, 2023: Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
- May 08, 2023: Viridian Therapeutics announces partnership with drug delivery innovator Enable Injections
- Sep 08, 2020: Enable Injections announces $25 million credit facility closed with Oxford Finance
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Enable Injections Inc Pipeline Products and Ongoing Clinical Trials Overview
- Enable Injections Inc Pipeline Products by Equipment Type
- Enable Injections Inc Pipeline Products by Indication
- Enable Injections Inc Ongoing Clinical Trials by Trial Status
- Enable Injections Inc, Key Facts
- Enable Injections Inc, Major Products and Services
- Enable Injections Inc Number of Pipeline Products by Development Stage
- Enable Injections Inc Pipeline Products Summary by Development Stage
- Enable Injections Inc Ongoing Clinical Trials by Trial Status
- Enable Injections Inc Ongoing Clinical Trials Summary
- Enfuse Differentiated Molecular Drug Delivery System - Product Status
- Enfuse Differentiated Molecular Drug Delivery System - Product Description
- enFuse Dual Vial Transfer System - Product Status
- enFuse Dual Vial Transfer System - Product Description
- enFuse On-Body Infusor - Product Status
- enFuse On-Body Infusor - Product Description
- enFuse Syringe Transfer System - Product Status
- enFuse Syringe Transfer System - Product Description
- enFuse Vial Transfer System - Product Status
- enFuse Vial Transfer System - Product Description
- Enfuse with SER-252 - Product Status
- Enfuse with SER-252 - Product Description
- Enfuse with SER-252 - A Study to Evaluate the Efficacy of Enable Enfuse with SER-252 in Subjects with Parkinson’s Disease
- Enable Injections Inc, Key Employees
- Glossary
- Enable Injections Inc Pipeline Products by Equipment Type
- Enable Injections Inc Pipeline Products by Development Stage
- Enable Injections Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- EvoEndo Inc
- Ximedica LLC
- Garwood Medical Devices LLC
- LegWorks Inc
- Donatelle
